Compare TROW & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TROW | WST |
|---|---|---|
| Founded | 1937 | 1923 |
| Country | United States | United States |
| Employees | 4802 | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.8B | 17.9B |
| IPO Year | 2000 | 2004 |
| Metric | TROW | WST |
|---|---|---|
| Price | $89.89 | $246.74 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $102.09 | ★ $319.43 |
| AVG Volume (30 Days) | ★ 2.0M | 712.8K |
| Earning Date | 05-01-2026 | 04-23-2026 |
| Dividend Yield | ★ 5.86% | 0.36% |
| EPS Growth | 0.98 | ★ 1.49 |
| EPS | ★ 9.24 | 6.79 |
| Revenue | $2,370,700,000.00 | ★ $2,886,900,000.00 |
| Revenue This Year | $7.13 | $6.76 |
| Revenue Next Year | $2.27 | $6.15 |
| P/E Ratio | ★ $9.60 | $36.18 |
| Revenue Growth | ★ 26.65 | 1.95 |
| 52 Week Low | $77.85 | $187.43 |
| 52 Week High | $117.02 | $322.34 |
| Indicator | TROW | WST |
|---|---|---|
| Relative Strength Index (RSI) | 45.05 | 53.53 |
| Support Level | N/A | $241.57 |
| Resistance Level | $106.82 | $251.73 |
| Average True Range (ATR) | 1.97 | 6.76 |
| MACD | 0.37 | 0.94 |
| Stochastic Oscillator | 78.74 | 82.51 |
T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of September, the firm had $1.767 trillion in managed assets, composed of equity (50%), balanced (35%), fixed-income and money market (12%), and alternative (3%) offerings. Approximately two-thirds of managed assets are held in retirement-based accounts, which provides T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.